Molecular Cancer

Titel Veröffentlichungsdatum Sprache Zitate
Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia2023/12/04English
The University of Kansas Cancer Center (KUCC), an NCI designated comprehensive cancer center2023/11/28English
Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer2023/03/20English
Mutation status of the KMT2 family associated with immune checkpoint inhibitors (ICIs) therapy and implicating diverse tumor microenvironments2024/01/15English
Mapping cancer biology in space: applications and perspectives on spatial omics for oncology2024/01/30English
Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma2024/01/10English
Deciphering tumor microenvironment: CXCL9 and SPP1 as crucial determinants of tumor-associated macrophage polarity and prognostic indicators2024/01/13English
Retraction Note to: Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway2022/09/29English
Thanking our 2014 peer reviewers2015/03/31English
Open access and beyond2006/09/06English
Another challenge for scientists2008/07/17English
Retraction Note: Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer2023/04/28English
Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome2024/02/21English
The construction of modular universal chimeric antigen receptor T (MU-CAR-T) cells by covalent linkage of allogeneic T cells and various antibody fragments2024/03/11English
Bladder-cancer-derived exosomal circRNA_0013936 promotes suppressive immunity by up-regulating fatty acid transporter protein 2 and down-regulating receptor-interacting protein kinase 3 in PMN-MDSCs2024/03/09English
Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine2024/03/09English
Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanoma2024/02/29English
circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis2024/03/08English
Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib2024/03/08English
Genetic fusion of CCL11 to antigens enhances antigenicity in nucleic acid vaccines and eradicates tumor mass through optimizing T-cell response2024/03/08English
Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression2024/03/08English
The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma2024/02/22English
Functional CRISPR screens in T cells reveal new opportunities for cancer immunotherapies2024/04/05English
Crosstalk between metabolism and cell death in tumorigenesis2024/04/04English
Therapy-induced senescent tumor cell-derived extracellular vesicles promote colorectal cancer progression through SERPINE1-mediated NF-κB p65 nuclear translocation2024/04/04English
The senescence journey in cancer immunoediting2024/04/01English
Cancer-derived exosomes as novel biomarkers in metastatic gastrointestinal cancer2024/04/01English
Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application2024/04/06English
Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC2024/04/06English
Cancer immunometabolism: advent, challenges, and perspective2024/04/05English